AM-2995

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameAM-2995

Drug Alias NameAM-2995

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionApelin receptor agonists

TargetsApelin receptor

Therapy Area/IndicationsHeart Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAmgen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmgen Inc

Active IndicationsN/A

Inactive IndicationsHeart Failure

ATC CodeN/A